Overall rank by patents
#46,240
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Defined Diagnostics, Llc
USPTO PatentsView assignee record - 5 granted patents across 6 technology areas, active 2017–2021. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES).
5
Total patents granted
6
CPC technology areas
16.2
Avg claims per patent
+50%
5-year filing velocity
The verdict
Defined holds 5 US patents across 6 technology areas, rank #46,240 of 50,000 tracked assignees.
- #46,240
- of 50,000 US assignees by volume
- Top 85%
- by Innovation Score (24.6/100)
- 16.2
- avg claims per patent
- +50%
- filing velocity, last 5 yrs
Portfolio overview
Defined Diagnostics, Llc has been granted 5 US utility patents between 2017 and 2021, placing Defined Diagnostics, Llc at rank #46,240 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.2 claims per patent with primary concentration in G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES). As a US Corporation, Defined Diagnostics, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Defined sits between Deeptek Inc. (5 patents, rank #46,236) and Dekati Oy (5 patents, rank #46,244) - the closest US assignees by grant volume. The composite Innovation Score of 24.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 2 in the 2015–2019 window, a +50% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Defined Diagnostics, Llc's 16.2 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Defined Diagnostics, Llc against peers pursuing similar technology classes.
Who files at Defined's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Deeptek
DeepTek Inc.
5 patents
- Deer Solutions
Deer Solutions LLC
5 patents
- Deerland Enzymes
Deerland Enzymes, Inc.
5 patents
- Defibrio AS
Defibrio AS
5 patents
- Definedcrowd
DefinedCrowd Corporation
5 patents
- Deftio
DeftIO LLC
5 patents
- Dehlsen Associates
Dehlsen Associates, LLC
5 patents
- Dekati Oy
Dekati Oy
5 patents
- Defined Diagnosti… ◀
Defined Diagnostics, LLC
5 patents
What this shows Defined holds 5 patents at rank #46,240, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Defined
By rank, the assignees closest to #46,240 in granted patent volume.
Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)
Other assignees with the most granted patents in Defined's primary technology class.
- The Regents Of The University Of California 1,153 in class
- Shimadzu Corporation 1,111 in class
- Saudi Arabian OIL Company 837 in class
- Halliburton Energy Services, Inc. 816 in class
- The Boeing Company 701 in class
- General Electric Company 634 in class
- Kla-tencor Corporation 583 in class
- Massachusetts Institute Of Technology 530 in class
Defined's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
25 Top 85% higher than 15% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 2 | 40.0% |
| 2021 | 3 | 60.0% |
Which technologies does Defined Diagnostics, Llc patent most?
Top 6 of 6 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Accelerating
Frequently Asked Questions
How many patents does Defined Diagnostics, Llc hold?
Defined Diagnostics, Llc holds 5 US granted patents filed between 2017 and 2021, spanning 6 technology areas.
What is Defined Diagnostics, Llc's Innovation Score?
Defined Diagnostics, Llc has an Innovation Score of 24.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Defined Diagnostics, Llc focus on?
Defined Diagnostics, Llc's top technology area is G01N (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES) with 5 patents. The company has filed patents in 6 CPC subclasses total.
Is Defined Diagnostics, Llc's patent filing rate increasing or decreasing?
Defined Diagnostics, Llc's recent filing velocity is +50% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Defined Diagnostics, Llc's patents?
Defined Diagnostics, Llc's patents average 16.2 claims each. This falls within the standard range, providing solid legal coverage.
How is the Defined Diagnostics, Llc patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Defined's 5 grants land it in the top 85% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Defined ranks #46,240 of 50,000. Top 50 holders
- Most of this portfolio concentrates in G01N - see who else leads that technology area. G01N leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.